| Literature DB >> 25138613 |
Jin-Woo Kim1, Sun-Jong Kim2, Myung-Rae Kim1.
Abstract
Our aim was to assess the feasibility of using leucocyte-rich and platelet-rich fibrin (L-PRF) for the treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in a single group study. After treatment with L-PRF, the response of each patient was recorded 1 month and 4 months postoperatively. Further assessments were made of the site, stage, concentration of c-terminal crosslinked telopepide of type 1 collagen, and actinomycosis. Among the total of 34 patients, 26 (77%) showed complete resolution, 6 (18%) had delayed resolution, and 2 (6%) showed no resolution. There was a significant association between the response to treatment and the stage of BRONJ (p=0.002) but no other significant associations were detected. This study has shown that it is feasible to use L-PRF for the treatment of BRONJ, but the effectiveness cannot be judged with this study design. Randomised prospective trials are needed to confirm this.Entities:
Keywords: Bisphosphonate; Growth factor; Osteonecrosis of the jaw; Platelet concentrate; Platelet-rich fibrin
Mesh:
Substances:
Year: 2014 PMID: 25138613 DOI: 10.1016/j.bjoms.2014.07.256
Source DB: PubMed Journal: Br J Oral Maxillofac Surg ISSN: 0266-4356 Impact factor: 1.651